Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Economics of serotonin 5-HT3 antagonists.

× No keyword cloud information.

7 in total

1. The budgetary impact of 5-HT3 receptor antagonists in the management of chemotherapy-induced emesis.

Authors: A L Jones; G J Lee; N Bosanquet
Journal: Eur J Cancer Date: 1992 Impact factor: 9.162

2. Cost and cost-effectiveness analysis of ondansetron versus metoclopramide regimens: a hospital perspective from Italy.

Authors: E Ballatori; F Roila; P Berto; V De Angelis; C Neri; A Olivieri; M Tonato; A Del Favero
Journal: Pharmacoeconomics Date: 1994-03 Impact factor: 4.981

Review 3. Granisetron. A pharmacoeconomic evaluation of its use in the prophylaxis of chemotherapy-induced nausea and vomiting.

Authors: G L Plosker; P Benfield
Journal: Pharmacoeconomics Date: 1996-04 Impact factor: 4.981

4. Impact of chemotherapy-associated nausea and vomiting on patients' functional status and on costs: survey of five Canadian centres.

Authors: B J O'Brien; J Rusthoven; A Rocchi; J Latreille; S Fine; T Vandenberg; F Laberge
Journal: CMAJ Date: 1993-08-01 Impact factor: 8.262

5. The real costs of emesis--an economic analysis of ondansetron vs. metoclopramide in controlling emesis in patients receiving chemotherapy for cancer.

Authors: D Cunningham; M Gore; N Davidson; M Miocevich; M Manchanda; N Wells
Journal: Eur J Cancer Date: 1993 Impact factor: 9.162

6. Economic evaluation of ondansetron: preliminary analysis using clinical trial data prior to price setting.

Authors: M J Buxton; B J O'Brien
Journal: Br J Cancer Suppl Date: 1992-12

7. Cost effectiveness of 5-hydroxytryptamine3 receptor antagonists: a retrospective comparison of ondansetron and granisetron.

Authors: N Johnson; N Bosanquet
Journal: Anticancer Drugs Date: 1995-04 Impact factor: 2.248

7 in total